
FOX04-DRI (10 mg)
FOX04‑DRI (Retro‑Inverso) is a synthetic peptide designed to interfere with the FOXO4/p53 interaction, enabling selective induction of apoptosis in senescent ce…
Half-life
Prolonged compared to native FOXO4 peptide (due to retro‑inverso design)
Delivery
Subcutaneous injection (after reconstitution in bacteriostatic water or suitable solvent)
Suggested dosage
Not specified
Usage
Mechanism of action
Benefits (4)
- Selective clearance of senescent cells
- Improved organ and tissue function
- Reduced aging‑related inflammatory signaling
- Enhanced insulin sensitivity and metabolic outcomes
Side effects (2)
- Limited human safety data
- Potential off‑target effects in non‑senescent cells

